Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells.

Huang SW, Chang CC, Lin CC, Tsai JJ, Chen YJ, Wu CY, Liu KT, Shieh JJ.

J Dermatol Sci. 2012 Mar;65(3):170-8. doi: 10.1016/j.jdermsci.2011.11.001. Epub 2011 Nov 16.

PMID:
22305615
2.

Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line.

Huang SW, Chang SH, Mu SW, Jiang HY, Wang ST, Kao JK, Huang JL, Wu CY, Chen YJ, Shieh JJ.

J Dermatol Sci. 2016 Mar;81(3):182-91. doi: 10.1016/j.jdermsci.2015.12.011. Epub 2015 Dec 29.

PMID:
26775629
3.

Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy.

Wang ST, Huang SW, Kao JK, Liang SM, Chen YJ, Chen YY, Wu CY, Shieh JJ.

J Dermatol Sci. 2015 May;78(2):108-16. doi: 10.1016/j.jdermsci.2015.02.008. Epub 2015 Feb 23.

PMID:
25766763
4.

Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells.

Huang SW, Liu KT, Chang CC, Chen YJ, Wu CY, Tsai JJ, Lu WC, Wang YT, Liu CM, Shieh JJ.

Br J Dermatol. 2010 Aug;163(2):310-20. doi: 10.1111/j.1365-2133.2010.09827.x. Epub 2010 Apr 26.

PMID:
20426785
5.

Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.

Vidal D, Matías-Guiu X, Alomar A.

Br J Dermatol. 2004 Sep;151(3):656-62.

PMID:
15377354
6.

Modification of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells.

Shieh JJ, Liu KT, Huang SW, Chen YJ, Hsieh TY.

J Invest Dermatol. 2009 Oct;129(10):2497-506. doi: 10.1038/jid.2009.83. Epub 2009 Apr 16.

7.

The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells.

Wang B, Ni Z, Dai X, Qin L, Li X, Xu L, Lian J, He F.

Mol Cancer. 2014 Apr 30;13:98. doi: 10.1186/1476-4598-13-98.

8.

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod.

Schön M, Bong AB, Drewniok C, Herz J, Geilen CC, Reifenberger J, Benninghoff B, Slade HB, Gollnick H, Schön MP.

J Natl Cancer Inst. 2003 Aug 6;95(15):1138-49.

PMID:
12902443
9.

Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.

Rahmani M, Aust MM, Attkisson E, Williams DC Jr, Ferreira-Gonzalez A, Grant S.

Cancer Res. 2013 Feb 15;73(4):1340-51. doi: 10.1158/0008-5472.CAN-12-1365. Epub 2012 Dec 12.

10.

Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells.

Schulze-Bergkamen H, Ehrenberg R, Hickmann L, Vick B, Urbanik T, Schimanski CC, Berger MR, Schad A, Weber A, Heeger S, Galle PR, Moehler M.

World J Gastroenterol. 2008 Jun 28;14(24):3829-40.

11.

Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down-regulation of Mcl-1 through inhibition of translation.

Rahmani M, Davis EM, Bauer C, Dent P, Grant S.

J Biol Chem. 2005 Oct 21;280(42):35217-27. Epub 2005 Aug 18.

12.

Functional and biological analysis of Bcl-xL expression in human osteosarcoma.

Wang ZX, Yang JS, Pan X, Wang JR, Li J, Yin YM, De W.

Bone. 2010 Aug;47(2):445-54. doi: 10.1016/j.bone.2010.05.027. Epub 2010 May 23.

PMID:
20580954
13.

Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathway.

Wu CS, Chen GS, Lin PY, Pan IH, Wang ST, Lin SH, Yu HS, Lin CC.

DNA Cell Biol. 2014 Oct;33(10):652-66. doi: 10.1089/dna.2014.2366. Epub 2014 Jun 13.

14.

The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.

Sung ES, Park KJ, Choi HJ, Kim CH, Kim YS.

Exp Cell Res. 2012 Aug 1;318(13):1564-76. doi: 10.1016/j.yexcr.2012.04.003. Epub 2012 Apr 10.

PMID:
22513214
15.

Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells.

Wang B, Chen L, Ni Z, Dai X, Qin L, Wu Y, Li X, Xu L, Lian J, He F.

Exp Cell Res. 2014 Nov 1;328(2):379-87. doi: 10.1016/j.yexcr.2014.08.039. Epub 2014 Sep 6.

PMID:
25196280
16.

Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1.

Zhan Z, Li Q, Wu P, Ye Y, Tseng HY, Zhang L, Zhang XD.

Autophagy. 2012 Jan;8(1):109-21. doi: 10.4161/auto.8.1.18319. Epub 2012 Jan 1.

PMID:
22108005
17.

Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.

Eichhorn JM, Alford SE, Sakurikar N, Chambers TC.

Exp Cell Res. 2014 Apr 1;322(2):415-24. doi: 10.1016/j.yexcr.2014.02.010. Epub 2014 Feb 17.

18.

Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells.

Selimovic D, Porzig BB, El-Khattouti A, Badura HE, Ahmad M, Ghanjati F, Santourlidis S, Haikel Y, Hassan M.

Cell Signal. 2013 Jan;25(1):308-18. doi: 10.1016/j.cellsig.2012.10.004. Epub 2012 Oct 15. Erratum in: Cell Signal. 2015 Mar;27(3):727. Cell Signal. 2015 May;27(5):1019-1020.

PMID:
23079083
19.

Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.

Song J, Chen Q, Xing D.

Exp Cell Res. 2013 Jun 10;319(10):1491-504. doi: 10.1016/j.yexcr.2013.03.012. Epub 2013 Mar 22.

PMID:
23524145
20.

Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients.

Burke MT, Morais C, Oliver KA, Lambie DL, Gobe GC, Carroll RP, Staatz CE, Sinnya S, Soyer HP, Winterford C, Haass NK, Campbell SB, Isbel NM.

Am J Clin Pathol. 2015 Apr;143(4):514-26. doi: 10.1309/AJCPQNB5WA3PLQBK.

PMID:
25780003

Supplemental Content

Support Center